$46.57
1.93% yesterday
Nasdaq, Nov 25, 09:17 pm CET
ISIN
US68213N1090
Symbol
OMCL

Omnicell, Inc. Stock price

$45.96
+6.46 16.35% 1M
+13.33 40.85% 6M
+8.33 22.14% YTD
+11.45 33.18% 1Y
-133.82 74.44% 3Y
-35.13 43.32% 5Y
+14.16 44.53% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.27 0.59%
ISIN
US68213N1090
Symbol
OMCL
Sector
Industry

Key metrics

Market capitalization $2.13b
Enterprise Value $2.15b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 16.12
EV/Sales (TTM) EV/Sales 2.02
P/S ratio (TTM) P/S ratio 2.00
P/B ratio (TTM) P/B ratio 1.73
Revenue growth (TTM) Revenue growth -10.26%
Revenue (TTM) Revenue $1.06b
EBIT (operating result TTM) EBIT $-21.56m
Free Cash Flow (TTM) Free Cash Flow $133.38m
Cash position $592.93m
EPS (TTM) EPS $-0.39
P/E forward 250.69
P/S forward 1.93
EV/Sales forward 1.95
Short interest 5.20%
Show more

Is Omnicell, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Omnicell, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Omnicell, Inc. forecast:

4x Buy
40%
6x Hold
60%

Analyst Opinions

10 Analysts have issued a Omnicell, Inc. forecast:

Buy
40%
Hold
60%

Financial data from Omnicell, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,064 1,064
10% 10%
100%
- Direct Costs 623 623
6% 6%
59%
441 441
15% 15%
41%
- Selling and Administrative Expenses 212 212
39% 39%
20%
- Research and Development Expense 88 88
9% 9%
8%
142 142
83% 83%
13%
- Depreciation and Amortization 163 163
69% 69%
15%
EBIT (Operating Income) EBIT -22 -22
13% 13%
-2%
Net Profit -18 -18
49% 49%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Omnicell, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Omnicell, Inc. Stock News

Neutral
Business Wire
4 days ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference.
Neutral
Business Wire
6 days ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering.
Neutral
Business Wire
8 days ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes.
More Omnicell, Inc. News

Company Profile

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Head office United States
CEO Randall Lipps
Employees 3,650
Founded 1992
Website www.omnicell.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today